















Title: How I see is how I feel. Identification of illness perception schema and 
its association with adaptation outcomes in multiple sclerosis – a 5-year 
prospective study 
 
Author: Jagoda Różycka 
 
Citation style: Różycka Jagoda. (2021). How I see is how I feel. Identification 
of illness perception schema and its association with adaptation outcomes in 
multiple sclerosis – a 5-year prospective study. „PLoS ONE” (2021, no. 10, 
art. no. e0258740, s. 1-26), DOI:10.1371/journal.pone.0258740 
RESEARCH ARTICLE
How I see is how I feel. Identification of illness
perception schema and its association with
adaptation outcomes in multiple sclerosis – a
5-year prospective study
Jagoda RóżyckaID*
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Abstract
The aim of the study was to assess the role of illness perception in adaptation to chronic dis-
ease among patients with relapsing-remitting multiple sclerosis (RRMS). The differences
between the obtained configurations of the illness perception components during four mea-
surements and the model of predictions of the values of adaptation indicators, i.e. depres-
sion, anxiety and quality of life during subsequent measurements, were analyzed. Illness
representation was assessed at baseline via the Illness Representation Questionnaire–
Revised. The adaptation indicators–anxiety, depression (measured by HADS) and quality of
life (measured by MSIS-29) were measured at baseline and three more times over a five-
year period. The k-means cluster analysis (with two-way and repeated measures ANOVA)
was conducted in a group of 90 patients (48.89% women and 51.11% men). Subsequently,
the mean values of depression, anxiety, physical and psychological quality of life were com-
pared between the clusters using the Kruskall-Wallis test. Finally, a cross-lagged panel
modeled for HADS and MSIS-29 subscales in each measurement occasion (T1-T4). Three
different illness perception clusters (Anxious, Realistic and Fatalistic Illness Perception
named AIP, RIP and FIP) were composed which differentiated the depression, anxiety,
quality of life level and age. FIP showed the lowest adaptation outcomes with small differ-
ences between AIP and RIP. It was also significantly characterized by the highest age. The
positive adaptation indicators were related to the RIP cluster. The model presented rather
satisfactory fit (χ2(48) = 81.05; CFI = .968; TLI = .925; SRMR = .050) with slightly inflated
RMSEA = .087 (90%CI .053-.120). Based on initial measurements of individual characteris-
tics, it was possible to predict the functioning of patients after several years. For patients
with AIP, the covariance of anxiety and depression was significant, for patients with RIP–
depression and anxiety, and for patients with FIP–depression. In addition, each of the vari-
ables was a predictor of subsequent measurements in particular time intervals, illustrating
the dynamics of changes. Results highlight that illness perceptions formed at the beginning
of RRMS are important for the process of adaptation to the disease. Moreover, they showed
the differences between the adaptation outcomes supporting the idea that a cognitive repre-
sentation might be important for the level of psychological functioning.
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Citation: Różycka J (2021) How I see is how I feel.
Identification of illness perception schema and its
association with adaptation outcomes in multiple
sclerosis – a 5-year prospective study. PLoS ONE
16(10): e0258740. https://doi.org/10.1371/journal.
pone.0258740
Editor: Marcello Moccia, Universita degli Studi di
Napoli Federico II, ITALY
Received: March 15, 2021
Accepted: October 4, 2021
Published: October 28, 2021
Copyright: © 2021 Jagoda Różycka. This is an
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Introduction
Multiple sclerosis (MS) is a progressive neurological disease characterized by an unpredictable
course of symptoms such as dizziness and vertigo, vision problems, stiffness, weakness, pain,
mobility problems, and cognitive difficulties that contribute to the development of disability
[1]. Most often, the disease starts with single relapses and periods of remission of symptoms
(the relapsing-remitting type). Consequently, coping with the illness requires numerous psy-
chosocial resources from the patient. The variability as well as the type of multiple sclerosis
symptoms is also high–the more symptoms a patient presents while presenting a higher level
of disability, the lower the quality of life and the lower the level of coping [2, 3]. The process of
adaptation to the disease is demanding in the case of MS due to its unpredictable course, the
presence of cognitive impairments, unknown cause, and lack of causal treatment, which
makes it difficult to control the disease [4]. The symptoms have a significant impact on the
patients’ quality of life (QoL) and emotional functioning (especially on the level of negative
emotions) [5, 6]. The quality of life level also affects other areas of life, such as social function-
ing and life roles [7, 8]. Many studies suggest a lower health related quality of life (HRQoL) in
individuals with MS compared to healthy individuals [8–11], as well as to individuals with
other chronic conditions such as inflammatory bowel disease, rheumatoid arthritis, epilepsy,
diabetes, and cardiovascular disease [12–14]. The quality of life of individuals with MS is
related to the degree of disability and the symptoms present [13, 15, 16], among other things.
Emotional functioning reflected in the levels of depression and anxiety is also an important
factor in the assessment of the adaptation process. Depressive disorders occur in up to 50% of
individuals living with multiple sclerosis [17–20]. Depression together with anxiety disorders
determine the level of the patient’s functioning [21]. The frequency of such disorders in this
group is generally 2–3 times higher compared to the general population. Numerous etiological
factors may influence the development of depression and anxiety in MS, including biological
mechanisms (e.g., hippocampal microglia activation, comorbid disease burden, CNS damage
in various areas), but also the stressors, threats and losses that accompany living with an
unpredictable and often permanently disabling disease [22].
Consequently, the factors are sought which might act as a buffer in minimizing the adverse
effects of multiple sclerosis. Identifying their importance may have direct application in indi-
vidual care, development of services, and promotion of new psychological intervention strate-
gies for patients with MS. One such factor is illness perception, understood as a complex and
dynamic cognitive schema, bringing together beliefs, knowledge, personal judgements and
opinions about the condition. An attempt was made to empirically distinguish in the studied
sample of MS patients subgroups composed of individuals who declare/have a similar illness
perception.
Illness perception
How a patient perceives their illness affects the quantity and quality of the efforts they make to
change their health situation as much as possible. The individual’s beliefs concerning their
chronic condition in the form of illness perception have an impact on their health and on the
treatment outcomes through active participation in the treatment process [23–25].
Cognitive representation of illness is a fundamental construct included in health behavior
models that explain the behaviors resulting from the patient role. Among the numerous mod-
els addressing cognitive illness representation, one of the most frequently cited is Leventhal’s
Self-Regulatory Model of illness perceptions [26–28], which describes the way in which people
interpret illness and cope with it. The model assumes that cognitive representation of illness
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contributes to adaptation by regulating the patient’s behavior faced with the illness, also influ-
encing the processing of incoming information. It is derived from the model for coping with
chronic disease [29]. The structure of illness perception consists of the following factors: iden-
tity–illness identification and knowledge about its symptoms, cause–beliefs about the factors
responsible for the occurrence of the disease, consequences–the patient’s beliefs about how the
disease will affect different areas of their life, timeline–expectations concerning the progress
and duration of the disease (whether it is chronic or temporary), coherence–having a coherent
and comprehensible illness perception, personal control/treatment control–sense of control
over the disease and over the treatment process, and emotional representation–emotional
responses towards the disease, sense of anxiety or lowered mood as a result of the condition
[30].
Illness perception according to the model by Maes et al. [29] determines the current assess-
ment of the illness situation and the associated behaviors. It is used to explain the psychological
and physical consequences of sudden and chronic illnesses [31]. Its utility has been empirically
validated in predicting well-being, including psychological well-being, for numerous diseases
[31], including rheumatoid [32], lung cancer [33], and ischemic heart disease and associated
myocardial [34, 35].
The components of illness perception are significantly related to the process of adaptation
to illness–in fact, they determine reactions to the symptoms that appear and their conse-
quences for individual functioning, mainly in the form of assessment of quality of life or emo-
tional functioning. Elements of illness perceptions such as uncertainty about prognosis and
symptoms, but also their impact on daily functioning and the ability to control them, are sig-
nificant for quality of life (mainly psychological), but also for depression and anxiety [3]. If the
symptoms of the disease can in themselves affect the health and well-being of patients, a nega-
tive illness perception can also result in reduced quality of life. A consequence of this is a num-
ber of compensatory strategies in the form of avoidance, over-involvement, or preoccupation
with anxiety. Various meta-analyses have shown that perceiving the illness as more severe and
having more consequences was associated with worse health outcomes than perceiving it more
positively [31, 36]. Research also suggests that illness perceptions can change over time [37–
41], nevertheless there is also data suggesting its stability over time ([42]. Living with a chronic
condition can gradually change the perception of the associated consequences, emotional
representation, and control. Consequently, different trajectories of illness perception over time
can be expected in individuals with different types of the illness. Initially, however, illness per-
ception will be related to the immediate emotional response to the diagnosis, and it may there-
fore be one of the important factors relevant for the assessment of the adaptation process
(especially if the illness perception stability hypothesis is accepted).
Configurations of illness perception components
The literature suggests the formation of specific configurations of illness perception features,
as they do not occur in an isolated form [43]. It has been noted that illness features can group
together to form patterns, fostering adaptation and health behaviors to a smaller or larger
extent [36]. McCorry et al. [42] analyzed the level of psychological functioning of women with
breast cancer just after the diagnosis, distinguishing two illness perception configurations.
One of them made it possible to predict lower levels of anxiety and depression after six
months. The women surveyed reported lower levels of distress when they believed that their
breast cancer would not last long and would not be cyclical, when they believed that their treat-
ment would be effective, when they did not believe their cancer to be serious or to have severe
consequences for their lives, and when they were unable to identify a clear cause of their
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disease. Importantly, illness perception remained stable in the respondents throughout the
study period, despite the change in disease status. This contrasts with the predictions of the
self-regulatory model and has important implications for the timing and type of psychological
intervention in this field. Other studies have observed changes in illness perception over time
among people with back pain [44] and asthma [45], while longitudinal studies conducted
among cancer patients have also shown that illness perception remains stable over time [46].
Livneh, Lott, and Antonak [47] also distinguished patterns of adaptation to chronic illness
based on differences in levels of adjustment, coping strategies, depression, anxiety and per-
ceived stress, as well as perceived health control. Patients were characterized by having adap-
tive, maladaptive and moderately adaptive levels of functioning based on several psychological
domains, including the cognitive domain of perceived control. Personal control is not the only
cognitive component, so taking into account also other variables related to the perceptions of
one’s illness may be important in mediating the relationship between illness characteristics
and the assessment of the quality of life in relation to the respective condition. Illness percep-
tion is a certain mental filter that influences emotional responses and further actions taken in
relation to the disease.
Based on the above results, it seems reasonable to expect that also in the group of patients
with multiple sclerosis it will be possible to distinguish illness perception configurations. This
study attempts to identify these configurations in patients in the early stages of the disease.
Illness perception and adaptation to illness
It has been suggested that illness perception may be important in explaining the effects of the
adaptation process in relation to biological variables [13]. In determining the effects of the
adaptation process, the presence of anxiety, depression and quality of life levels are taken as
indicators [48, 49]. Research has shown that elements of illness perception such as uncertainty
about prognosis and symptoms, but also their impact on daily functioning and the possibility
of controlling them, are important for quality of life (mainly psychological) but also for depres-
sion and anxiety [3]. Identifying the structure of illness perception makes it possible to conjec-
ture about the potential risk of states of depression or anxiety, or reduced quality of life in
general. High levels of depression and anxiety may lead to worse cooperation with the physi-
cian, to the emergence of risky behaviors or a reduction in health behaviors, chronic inflam-
mation of the body due to chronic tension or suicidal thoughts/attempts (Patten, [22]. It seems
important, therefore, to investigate whether differences can be observed in adaptation indica-
tors in the illness perception configurations distinguished.
Dynamics of change of adaptation indicators in individuals diagnosed with
MS
It seems that the observations from cross-sectional studies concerning higher levels of depres-
sion and anxiety in a group of people with multiple sclerosis do not make it possible to draw
conclusions about the possible factors that might explain the variation in their levels or predict
their future values. Depressiveness and anxiety, on the one hand, intensify with time and as
the disease progresses [50], but they can also be lower than in the initial phases of the disease
as a result of the adaptation process [51, 52].
Research suggests that depression may be unrelated to disease severity [53, 54]. Addition-
ally, it may be associated with unpredictability and unpredictable prognosis in MS [53]. Lower
depression levels have also been observed in individuals with progressive MS compared to
those with relapsing MS [55]. On the other hand, the level of anxiety peaks after learning the
diagnosis and decrease over time–it is considered a predictor of the adaptation process [56].
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Researchers argue that the uncertainty accompanying the course of the disease is important
(in a progressive course, patients expect gradual loss of function, whereas in a relapsing-remit-
ting course, symptoms intensify or diminish in a very intrusive manner) [3, 57]. Consequently,
it can be assumed that the role of depressiveness and anxiety will depend on illness perception.
Zhang et al. [58], in their study of neck and head cancer, identified a negative illness perception
as burdened by more symptoms of the illness, with significant impact on functioning, longer
duration and less control over its treatment and course. In that study, perceived symptoms of
illness were a predictor of the level of psychological distress, i.e. of high levels of anxiety and
depression. One may therefore ponder on the potential differences in the relationships
between depression, anxiety and quality of life depending on the patient’s illness perception–it
can be expected that in the case of adaptive illness perception, with fewer perceived symptoms
associated with MS, lower levels of depressiveness and anxiety will predict lower values of
these variables in the future, while at the same time these values in the respective group will be
lower, and the relationship will be stronger.
According to Bassi et al. [59], illness perception characterized by illness coherence and high
levels of personal control and treatment control will be associated with better adjustment,
while high levels of negative emotions and the belief that the symptoms are cyclical will be
associated with worse adjustment. Moreover, the way of perceiving the symptoms can change
the direction of the adaptation process [41, 60]. This has also been demonstrated in various
diseases such as heart conditions [61]. It has been found that attitudes towards the illness and
the accompanying emotions increased or decreased depression, anxiety, and quality of life.
This affected the nature of the adjustment and recovery process. Therefore, it can be assumed
that the distinguished configurations of illness perception that differ in terms of quality of
adaptation will favor its different directions, and therefore different levels of depression, anxi-
ety, and quality of life.
Current study
The main aim of the current study is to assess the role of illness perception in adaptation to
multiple sclerosis. The specific objective of the study is to assess the levels of depressiveness,
anxiety, and illness-related quality of life among patients with multiple sclerosis and to assess
the possibility of predicting their levels depending on the nature of illness perception. A longi-
tudinal design was used in this research. Using longitudinal studies will make it possible to
assess the importance of illness perception in evaluating the risk of mental disorders as symp-
toms of adaptation difficulties and the level of quality of life. The development of depressive
and anxiety disorders has an adverse impact on the course of the illness, the treatment, as well
as the patient’s overall functioning. This in turn leads to questions as to whether illness percep-
tion will group together patients with multiple sclerosis on the basis of its components and
their configuration.
It is expected, on the basis of the results of the studies described above, that it will be possi-
ble to distinguish three types of illness perception: adaptive, moderately adaptive, and mal-
adaptive (Hypothesis 1). It is presumed that an adaptive illness perception will be associated
with fewer perceived symptoms, less intense chronicity beliefs, a higher sense personal con-
trol/treatment control, and less intense negative emotions. Moderately adaptive and maladap-
tive illness perception types will be characterized, accordingly, by a higher number of
symptoms and a stronger belief about chronicity and severe consequences, lower personal
control, and higher levels of negative emotions. The value of distinguishing specific illness per-
ception patterns consists in the possibility of adapting psychoeducation concerning the illness
to the individual’s specific beliefs about their condition. This approach is also consistent with
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the theoretical framework of illness representation, where illness components tend to combine
to form representations of the overall perception of the illness.
When distinguishing the different configurations of illness perception, it seems important
to check whether they differ in terms of the indicators of the adaptation process. It is also pre-
dicted that the group of individuals with an adaptive illness perception will present lower levels
of anxiety and depression and higher levels of quality of life than those with moderately adap-
tive and maladaptive illness perception (Hypothesis 2)
Finally, given the longitudinal nature of the research, it seems reasonable to check whether
and how adaptation indicators, i.e. depression, anxiety, and quality of life during the successive
measurements, may be related to one another in the consecutive measurements, making it
possible to predict their values over time. The direction of these relationships will differentiate
the individual configurations. It is assumed that depressiveness, anxiety, and quality of life at
T1 are predictors for the same variables at T2, at T2 they are predictors for T3, and at T3 they




The study consisted of four measurements, during which the study subjects were given a set of
questionnaires. During the first meeting, as part of a routine medical examination, a neurolo-
gist conducted a personal questionnaire and performed a cognitive function test. In the main
part of the study, respondents completed the following questionnaires: Illness Representation
Questionnaire–Revised (IPQ-R), the Hospital Anxiety and Depression Scale (HADS) to assess
depression and anxiety levels, and MSIS-29 to assess quality of life. The measurements were
repeated three times (T2, T3, T4), except for the first measure (T1). The intervals between T1,
T2 and T3 were three months, and between T3 and T4 they were four years (the dispropor-
tionate time between the measurements resulted from the possibilities of collecting them over
such a period). The intervals fixed between the measurements resulted from the schedule of
outpatient care appointments for patients with multiple sclerosis, the final measurement
resulted from the possibilities the researcher had and from the extended interval between the
successive outpatient appointments. Two patients did not show up for the second appoint-
ment, six patients for the third one, and 11 patients for the fourth one. This represents <3% of
the whole group at the second meeting, 6% at the third meeting, and 12% of the patients at the
fourth meeting, respectively. Missing data were managed using the multiple imputation
method as recommended by Kang [62]. In order to deal with missing data, a multiple substitu-
tion technique was applied in SPSS, indicating the variables where data were missing. All data
gaps were analyzed. Estimated data gaps were as follows: 16.9% in the first measurement,
18.5% in the second, 22.2% in the third, and 26.9% in the fourth measurement. First, the sys-
tems of all missing values of the variables were analyzed and then, through substitution models
(five imputations), the gaps were filled using regression analysis.
Participants
Patients were qualified for the study at a neurology ward or a neurology outpatient clinic ini-
tially by the researcher and by a team of physicians working at the respective facilities. The
final group, N = 90 of the 425 subjects in total, 44 women (48.89%) and 46 men (51.11%), was
selected on the basis of the following criteria: diagnosis of relapsing-remitting multiple sclero-
sis (the most frequently diagnosed form of multiple sclerosis, especially in the early stages of
the disease and at the same time demanding for the adaptation process due to alternating
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periods of remission and relapses), maximum four years after diagnosis [7], EDSS disability
level� 4, no cognitive impairment (MoCA >26,), no relapse in the last three months from the
start of the study. The Expanded Disability Status Scale (EDSS) ranges from 0.0 (no neurologi-
cal symptoms) to 10.0 (death due to the disease). The scale is based on the patient’s physical
abilities and deficits within various functional systems. The higher the scale score, the greater
the disability. A score of 4.0 means the patient is fully mobile without aid, self-sufficient, able
to function for more than 12 hours a day despite severe difficulties related to particular symp-
toms, and able to walk without assistance and rest for about 500 meters. The current study
assumes that 4.0 is equivalent to preserved daily functioning–thus objectively minimizing the
occurrence of low quality of life in the physical aspect. In the case of antidepressant treatment
initiated before entering the study, patients were consulted by a psychiatrist to determine the
advisability of the treatment. In each case, the psychiatrist determined the absence of co-occur-
ring depressive disorders, and the patients’ treatment was initiated before the diagnosis of mul-
tiple sclerosis for the following reasons declared by the patients: crisis triggered by another
event, low level of behavioral activation, and psychomotor retardation (in the last two cases,
these were most probably symptoms of multiple sclerosis).
All patients gave their written informed consent. The study was approved in the first stage
by the committee opening the doctoral dissertation procedure (2016), the follow-up was sub-
ject to a separate assessment by the university’s local ethics committee and obtained approval
(IRB No. 7.2019). 33% of the respondents had completed secondary school, 48% had higher
education, and 15% had primary education. The minimum time from the onset of first symp-
toms was 12 months and the maximum time was 132 months. The minimum number of
relapses among the study subjects was one and the maximum number was seven. Among the
study groups, 62% (56 respondents) were participants of drug programs. Eight individuals
were treated with antidepressants, accounting for less than 9% of the study group. The average
level of disability over the years–Kurtzke EDSS for the study subjects was M = 2.4 (SD = 0.8).
Measures
The Illness Perception Questionnaire–Revised (IPQ-R; [30]. The IPQ-R contains the identity
subscale with 14 symptoms often present during illness (e.g. pain, headache and dizziness), the
seven subscales (a total of 38 items) assessing timeline acute/chronic (“My illness will last a
short time”), consequences (“My illness does not have much effect on my life”), personal con-
trol (“What I do can determine whether my illness gets better or worse”), treatment control
(“My treatment will be effective in curing my illness”), coherence (“My illness is a mystery to
me”), timeline cyclical (“My illness is very unpredictable”), emotional representations (“Hav-
ing this illness makes me feel anxious”) and the cause scale (e.g. stress, worry, germ, overwork).
Items in the main section are rated on the original 5-point Likert type scale: strongly disagree,
disagree, neither agree nor disagree, agree, and strongly agree. The third Cause section was not
included in the study due to the high percentage of omissions. The reliability of the Polish ver-
sion conducted for the purposes of the study measured by the alpha coefficient was Identity =
.81, Timeline Chronic .60, Timeline Cyclical = .60, Consequences = .75, Personal Control =
.59, Treatment Control .86, Illness Coherence .92, and Emotional Representation = .70.
The Hospital Anxiety and Depression Scale (HADS) was constructed by Zigmond and
Snaith [63]. The scale assesses the intensity of subjective depression and anxiety in the last
week. The Polish adaptation was performed by de Walden-Gałuszko, Majkowicz, and Choj-
nacka-Szawłowska [64]. It consists of the Anxiety Scale and the Depression Scale. The answers
are assessed on a 4-point Likert-type scale–the higher the number of points, the greater the
severity of psychopathological symptoms. The reliability of the Polish version conducted for
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the purposes of the study measured by the alpha coefficient was .87 for the Depression Scale
and .76 for the Anxiety Scale.
The Multiple Sclerosis Impact Scale (MSIS-29; [65]) is the scale assessing the impact of MS
on the quality of life of the subjects in the physical and mental dimensions (Polish adaptation
by Jamroz-Wiśniewska et al. [66]). It consists of 29 questions, of which the first 20 are related
to the physical status, and the other questions to the mental state of respondents. The range of
the results is from 0 to 100 points. The higher the score, the worse the quality of life. In the
study, the scale alpha reliability was .92 for the physical dimension subscale and .94 for the psy-
chological dimension subscale.
Statistical analysis
Descriptive statistics were calculated for demographic variables, depression and anxiety scales
from the HADS questionnaire and quality of life variables from the MSIS-29 questionnaire
(general, physical and psychological). The decision was made to choose two dimensions of
quality of life due to the possibility of obtaining specific findings compared to the overall level
of quality of life. Basic r-Pearson correlations were performed. Illness perception configura-
tions were distinguished using cluster analysis with the k-means clustering algorithm–the best
fit was obtained with three clusters (interpreted respectively as AIP–anxious illness perception,
RIP–realistic illness perception, and FIP–fatalistic illness perception). Subsequently, the mean
values of depression, anxiety, physical and psychological quality of life were compared between
the individual clusters using the Kruskall-Wallis test.
Finally, a cross-lagged panel modeled for HADS and MSIS-29 subscales in each measure-
ment occasion (T1–T4). All variables were modeled as observed variables with error terms
included to adjust for external factors that may contribute to observed effects. Model fit was
assessed using the Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), Root Mean Square
Error of Approximation (RMSEA) with 90% CI and χ2. A good fit was recognized when CFI
and TLI were higher than 0.90 and RMSEA and SRMR was close or below .08 and χ2/df of 2.00
or below (Kline, 2005). Model parameters were then compared between AIP, RIP and FIP
groups allowing for comparisons of relations of anxiety, depression and physical and psycho-
logical quality of life in time depending on profile of illness perception.
Analyses were conducted in IBM SPSS Statistics 26 (IBM, 2018) and Mplus 7 (Muthén,
Muthén, 2012).
Results
The descriptive statistics are included in Tables 1 and 2.
As part of preliminary data analysis, r-Pearson correlations were performed: (1) between
the illness perception subscales and medical variables, (2) between the illness perception
subscales and adaptation indicators in each measure. A negative correlation was observed
Table 1. Demographic and disease characteristics.
M Min Max SD
Age 29.50 19 50 8.26
EDSS 2.41 1 4 0.84
Number of months from first symptom onset 27.72 12 132 24.12
Number of months from diagnosis 24.90 12 100 15.04
Number of months from last relapse 13.67 3 24 5.87
Number of relapses 1.47 1 7 1.17
https://doi.org/10.1371/journal.pone.0258740.t001
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between age and perception of MS as a chronic disease (r = -.335), as well as between age
and the perception of chronicity of the disease (r = -.232, p< .05). Furthermore, a positive
association was observed between the number of relapses in general and the perception of
MS as cyclical (r = .239). When analyzing adaptive indicators, the perception of MS as
chronic was negatively associated with anxiety (for T1-4 r between .243 and .367), depres-
sion (for T1-3 r between .255 and .410), and quality of life (for T1-3 r between .228 and
.275). Similar results were found for illness coherence and treatment control. Emotional
representation was positively associated with quality of life results. The results are presented
in Tables 3 and 4.
Cluster analysis with the k-means clustering algorithm was performed to distinguish the
illness perception configurations. The analysis revealed three clusters, defined as Anxious
Illness Perception (AIP), Realistic Illness Perception (RIP), and Fatalistic Illness Perception
(FIP). Other solutions suggesting the presence of fewer or more clusters demonstrated
worse fit. The system of variables and clusters is shown in Fig 1. Table 5 shows the mean val-
ues of the variables for each cluster and the results of the variance analysis, carried out to
assess the significance of the variability of the results within the identified clusters. Its
results indicate the significance of the differences between clusters (p < .001) for all
components.
Table 2. The IPQ-R, HADS and MSIS-29 descriptive statistics.
N M Min Max SD
Symptoms 90 9.42 2 19 4.29
Timeline chronic 90 21.18 12 26 3.33
Timeline cyclical 90 13.94 10 17 2.11
Consequences 90 19.94 11 27 4.30
Personal control 90 19.14 13 25 2.60
Illness coherence 90 15.26 11 21 2.85
Treatment control 90 16.96 11 22 3.66
Emotional representation 90 21.38 15 28 3.11
Depression (T1) 90 4.62 0 9 2.42
Depression (T2) 88 4.23 0 12 2.48
Depression (T3) 84 4.02 0 10 2.36
Depression (T4) 79 2.87 0 8 1.74
Anxiety (T1) 90 5.50 2 10 2.47
Anxiety (T2) 88 4.23 1 9 1.94
Anxiety (T3) 84 4.22 1 11 2.21
Anxiety (T4) 79 2.68 1 8 1.33
Quality of life (T1) 90 70.70 29 128 24.69
Quality of life (T2) 88 64.80 26 120 24.74
Quality of life (T3) 84 61.76 25 119 26.65
Quality of life (T4) 79 51.04 29 135 23.57
Physical QoL (T1) 90 50.28 20 97 18.40
Physical QoL (T2) 88 47.26 20 93 19.75
Physical QoL (T3) 84 45.48 20 89 21.15
Physical QoL (T4) 79 37.25 20 92 18.82
Psychological QoL (T1) 90 19.68 9 39 8.08
Psychological QoL (T2) 88 17.61 9 31 6.56
Psychological QoL (T3) 84 16.39 9 33 7.02
Psychological QoL (T4) 79 13.78 9 45 6.49
https://doi.org/10.1371/journal.pone.0258740.t002
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Cluster 1. Anxious Illness Perception (30 patients)–patients from this cluster scored high
on perceived symptoms, and negative consequences of illness. They obtained moderate
scores on personal control and illness coherence. They scored high on the level of negative
emotions.
Table 3. Pearson correlation coefficients between IPQ-R subscales, age and medical characteristics of MS.
SYM T–CH T–CY PC CONS COH TC ER
Age .150 -.335� -.162 -.202 -.109 -.192 -.232� .078
Months from the first symptom .163 -.136 -.194 .005 .113 -.093 -.077 -.065
Months from the diagnosis .086 -.024 -.100 .020 .152 -.104 -.126 .001
Months from the first relapse– 1st measure -.026 -.138 -.067 -.153 .239� -.169 -.026 .014
Months from the last relapse– 4th measure -.077 .065 .077 .179 .057 .056 .193 -.024
Number of relapses– 1st measure -.003 .010 -.218� .168 .025 -.274� -.153 .164
Number of relapses– 4th measure -.004 -.102 .115 -.144 .046 -.060 .063 .002
Number of relapses through the disease .133 .060 .235� .146 -.039 .155 .096 -.111
EDSS– 1st measure .111 .030 .056 -.060 .200 .186 .200 -.114
EDSS– 4th measure .148 -.054 .142 -.054 .176 .210 .184 -.179
�p< .05
Legend: SYM–symptoms, T-CH–timeline-chronic, T-CY–timeline-cyclical, PC–personal control, CONS–consequences, COH–coherence, TC–treatment control, ER–
emotional representation.
https://doi.org/10.1371/journal.pone.0258740.t003
Table 4. Pearson correlation coefficients between IPQ-R subscales, HADS (depression and anxiety) and MSIS-29 with subscales (quality of life, physical QoL and
psychological QoL).
SYM T–CH T–CY PC CONS COH TC ER
Depression (T1) .072 -.236� -.186 -.110 -.121 -.273� -.185 .063
Depression (T2) .080 -.410� -.402� -.202 -.145 -.445� -.435� .122
Depression (T3) .125 -.382� -.357� -.207 -.181 -.449� -.421� .215
Depression (T4) .102 -.255� -.341� -.034 -.216 -.360� -.380� .221
Anxiety (T1) .108 -.248� -.121 -.032 .070 -.121 -.046 .045
Anxiety (T2) .155 -.243� -.147 -.104 ,071 -.272� -.224� .138
Anxiety (T3) .082 -.367� -.195 -.272� .061 -.310� -.217 .113
Anxiety (T4) -.076 -.219 -.106 -.230� -.008 -.269� -.248� .259�
Quality of life (T1) .275� -.190 -.142 -.041 .088 -.179 -.001 .107
Quality of life (T2) .235� -.338� -.209 -.195 -.029 -.343� -.163 .244�
Quality of life (T3) .228� -.387� -.306� -.213 -.081 -.448� -.264� .333�
Quality of life (T4) .108 -.297� -.282� -.010 -.171 -.447� -.300� .418�
Physical QoL (T1) .246� -.145 -.164 -.005 .077 -.190 -.012 .114
Physical QoL (T2) .202 -.322� -.190 -.206 -.008 -.314� -.143 .218
Physical QoL (T3) .234� -.360� -.308� -.188 -.068 -.426� -.236� .334�
Physical QoL (T4) .118 -.344� -.303� -.132 -.169 -.432� -.289� .395�
Psychological QoL (T1) .335� -.240� -.173 -.070 -.019 -.239� -.058 .159
Psychological QoL (T2) .275� -.301� -.213 -.117 -.083 -.343� -.190 .257�
Psychological QoL (T3) .154 -.382� -.228� -.247� -.097 -.412� -.293� .253�
Psychological QoL (T4) .051 -.080 -.148 .019 -.130 -.370� -.251� .373�
�p<0.05.
Legend: SYM–symptoms, T-CH–timeline-chronic, T-CY–timeline-cyclical, PC–personal control, CONS–consequences, COH–coherence, TC–treatment control, ER–
emotional representation.
https://doi.org/10.1371/journal.pone.0258740.t004
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Cluster 2. Realistic Illness Perception (33 patients)–patients in the second cluster presented
a realistic illness perception, involving low levels of perceived symptoms and high levels of
belief in the cyclical nature of the disease. This group displayed high levels of personal control
over MS and higher levels of illness coherence compared to other patients. These patients pre-
sented low levels of negative emotions.
Fig 1. Standard means of clusters distinguished in cluster analysis for illness representation in T1 AIP (n = 30), RIP (n = 33) and FIP (n = 27).
https://doi.org/10.1371/journal.pone.0258740.g001
Table 5. Mean values of illness perception components in the individual clusters.
Illness representation Anxious IP SD Realistic IP SD Fatalistic IP SD F (2.87) p
Identity 12.033 4.567 7.152 3.183 9.296 3.593 12.900 < .001
Timeline chronic 22.267 3.269 22.606 2645 18.222 2.082 22.796 < .001
Timeline cyclical 13.133 2.193 15.515 1.302 12.926 1.662 21.157 < .001
Personal control 18.167 2.151 20.909 2.127 18.074 2.464 16.173 < .001
Consequences 24.900 1.936 18.000 3.335 16.815 1.415 94.778 < .001
Illness coherence 14.467 1.852 18.182 1.236 12.556 1.695 97.141 < .001
Treatment control 16.500 2.838 20.576 1.347 13.037 1.372 109.004 < .001
Emotional representation 22.067 2.815 19.212 1.453 23.259 3.381 19.358 < .001
https://doi.org/10.1371/journal.pone.0258740.t005
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Cluster 3. Fatalistic Illness Perception (27 patients)–the third cluster of cognitive represen-
tations demonstrated the highest level of negative emotions related to illness perception. The
patients displayed low levels of perceiving the disease as chronic or cyclical, low levels of nega-
tive consequences, sense of control over the disease and sense of coherence in terms of knowl-
edge and information about MS.
The Kruskal-Wallis test with post-hoc comparisons was conducted to compare the mean
values of quality of life, depression and anxiety measures in the individual clusters (Table 6).
Post-hoc comparisons indicated that Fatalistic and Realistic IP differed in every studied
area, namely depression (in all timepoints), anxiety (3rd and 4th stage), psychological quality of
life (2nd to 4th stage), and physical quality of life (2nd to 4th stage). Differences in the same areas
and stages were observed between FIP and AIP. On the other hand, AIP differed from RIP in
fewer areas: 2nd and 3rd stage in depression and 3rd and 4th stage in anxiety.
Overall, FIP achieved the lowest scores in adaptational outcomes in most stages of all stud-
ied areas, comparing to AIP and RIP. It was shown that FIP scored low on positive health indi-
ces and high on negative health indices.
The lack of statistically significant differences between AIP and RIP was noted in quality of
life and anxiety (except 3rd stage). This would indicate a similar nature of these clusters–with
AIP and RIP potentially based on a real heath threat but still actively coping and confronting
with stressors. The positive adjustment indicators were related to the Realistic IP cluster–with
higher psychological and physical quality of life connected with MS.
In order to analyze the relations of depression, anxiety, and physical and psychological
quality of life over time, a cross-lagged panel analysis was conducted on HADS and MSIS-29
scores in each timepoint. The model presented rather satisfactory fit (χ2(48) = 81.05; CFI =
.968; TLI = .925; SRMR = .050) with slightly inflated RMSEA = .087 (90%CI .053-.120). Cluster
groups under this model are presented in Figs 2–4.
In RIP, positive predictions of each subsequent measurement by the previous one were
observed (except psychological QoL in T3 and T4), as well as positive cross-predictions by pre-
vious timepoint, such as physical QoL in T1 predicted anxiety in T2. In AIP, no significant
relations were observed between T3 and T4 in anxiety and depression, which can be seen in
RIP and FIP. AIP and FIP, compared to RIP, present overall weaker correlations between
HADS and MSIS-29 subscales in all timepoints, especially T1. In the last timepoint, FIP pre-
sented no correlations between variables, except QoL subscales, and correlations in AIP were
positive, as opposed to the negative ones in RIP.
Discussion
The research has shown that patients with multiple sclerosis differ in terms of their illness per-
ception and components of the latter at the early stage of the disease. The configurations that
developed differed in terms of the levels of depression, anxiety, and quality of life depending
on the measurement timepoint, accentuating the important role of temporal dynamics in the
assessment of adaptation indicators. In addition, the variables analyzed in each measure were
significant predictors of the level of other adaptation indicators in subsequent years. This con-
firms the multifactorial nature of the adaptation process, which, when observed from the
moment of diagnosis, makes it possible to implement therapeutic interventions matching to
the cognitive representation of the disease. The dynamics of adaptation indicators is evidence
of the changes that occur in the coping process, worthy of attention on the part of clinicians.
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Table 6. Comparisons of aspects of adaptation between AIP, RIP and FIP clusters.
Timepoint Cluster Mean Rank Kruskal-Wallis (p) Post-hoc (p)
AIP RIP
Depression T1 AIP 42.42 .032
RIP 39.53
FIP 56.22 < .05 < .05
T2 AIP 40.10 < .001
RIP 34.52 < .05
FIP 62.08 < .05 < .05
T3 AIP 40.48 < .001
RIP 33.42 < .05
FIP 57.67 < .05 < .05
T4 AIP 37.32 < .05
RIP 34.76
FIP 49.98 < .05 < .05
Anxiety T1 AIP 43.08 .517
RIP 43.83
FIP 50.22
T2 AIP 42.53 .087
RIP 39.23
FIP 53.39
T3 AIP 38.95 .011
RIP 37.49 < .05
FIP 56.02 < .05 < .05
T4 AIP 37.06 .014
RIP 35.58
FIP 52.33 < .05 < .05
Physical QoL T1 AIP 47.20 .231
RIP 39.61
FIP 50.82
T2 AIP 44.33 .026
RIP 36.62
FIP 54.69 < .05 < .05
T3 AIP 44.41 < .05
RIP 32.72
FIP 53.70 < .05 < .05
T4 AIP 40.46 .012
RIP 31.84
FIP 50.50 < .05 < .05
Psychological QoL T1 AIP 44.45 .098
RIP 39.52
FIP 53.98
T2 AIP 41.33 .010
RIP 37.46
FIP 56.98 < .05 < .05
T3 AIP 39.55 < .05
RIP 35.72
FIP 55.65 < .05 < .05
T4 AIP 40.74 < .05
RIP 32.69
FIP 49.04 < .05 < .05
https://doi.org/10.1371/journal.pone.0258740.t006
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Illness perception
It was assumed that it would be possible to distinguish adaptive, moderately adaptive and mal-
adaptive illness perceptions. Hypothesis 1 was confirmed by distinguishing three configura-
tions of illness perception components, named respectively: RIP–realistic illness perception
(adaptive), AIP–anxious illness perception (moderately adaptive), and FIP–fatalistic illness
perception (maladaptive).
An anxious illness perception was characterized by perceiving the illness as chronic, mainly
by focusing on the physical symptoms and perceived negative consequences of the illness
(which may be exaggerated and never actually appear). These characteristics significantly dif-
ferentiated the respective patients from those belonging to the other two groups. At the same
time, there was a moderate level of control and negative emotions.
Patients presenting a realistic illness perception had the lowest level of perceived symptoms,
most likely corresponding to the situation of relatively low disability and disease progression.
They indicated a higher level of personal and treatment control, which was a significant differ-
ence compared to the other groups. MS was more comprehensible for these patients, which
may explain the higher level of coherence compared to AIP. At the same time, the level of per-
ceived chronicity and cyclicality was moderate. This group also had the lowest levels of nega-
tive emotions.
As opposed to the other types of illness perception, the third group of patients, those with
fatalistic illness perception (FIP), presented mostly negative aspects of illness representation–
low control over the course of the disease and high levels of negative emotions. Patients with
Fig 2. Cross-lagged panel model of MSIS-29 and HADS over four timepoints for AIP (n = 30). Note: Solid arrows are p< .05; dashed arrows are nonsignificant;
numbers above arrows indicate standardized coefficients.
https://doi.org/10.1371/journal.pone.0258740.g002
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FIP were also the oldest participants in the study. They perceived a moderate number of symp-
toms of the disease, but did not assess the latter as chronic or cyclical–suggesting a resigned atti-
tude or even denial that the illness is real. The patients displayed an attitude in which they did
not want to recognize the different characteristics of the disease, trying to function, as it were, in
detachment from it. Aspects such as the lowest perceived chronicity or negative consequences
suggest that they may present avoidant behaviors that do not confront the reality of the illness.
The above illness perception types are consistent with the findings of studies concerning ill-
ness perception in various chronic conditions: chronic pain [67], arterial hypertension [68],
type 2 diabetes [69], or early stages of breast cancer [42]. The characteristics differentiating the
individual clusters were similar factors obtained in the current study–perceived symptoms, con-
sequences, level of negative emotions, level of control and perception of chronicity of the course
of the disease. Patients displaying the highest level of adaptation tried to perceive fewer physical
symptoms and fewer direct effects of the disease. At the same time, they declared a higher level
of control over the disease, also in the context of the treatment process, and lower levels of
depression and anxiety. The consistency of the results suggests that chronic diseases may share
a similar cognitive background in terms of how patients perceive and experience their illness.
Differences in variable levels depending on illness perception configuration
Data were also obtained suggesting significant differences between the profiles in terms of the
variables analyzed. Hypothesis two was confirmed. Patients presenting a realistic illness per-
ception scored lower on depression and anxiety compared to the other patients, and perceived
Fig 3. Cross-lagged panel model of MSIS-29 and HADS over four timepoints for RIP (n = 33). Note: Solid arrows are p< .05; dashed arrows are nonsignificant;
numbers above arrows indicate standardized coefficients.
https://doi.org/10.1371/journal.pone.0258740.g003
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significantly fewer limitations and negative effects of the illness over the study period. This is a
significant result for the final measure (T4) which persisted after four years and with gradual
progression of the disease.
RIP scored significantly highest on psychological quality of life and in the physical domain.
This suggests the highest level of adaptation to illness, confirming the findings of the research
by Hobro et al. [67] and the results obtained by Graham et al. [70]. Configurations associated
with indicators suggesting higher levels of adaptation were associated with realistic views on
duration, greater coherence, sense of control, lower levels of negative emotions associated with
the illness, and low levels of perceived symptoms (regardless of the disease progression).
In the present study, FIP and AIP subjects obtained similar scores except in a few dimen-
sions. The structure of these representations was similar in terms of symptom perception,
cyclicality, control over MS, coherence, and negative emotions. Differences emerged in the
perception of the consequences and chronicity–patients in the AIP group carefully identified
negative consequences being aware of the chronicity of the condition, while patients in the FIP
group displayed the opposite attitude. They focused neither on the consequences nor on the
belief in chronicity. As a result, the latter group scored the lowest on adaptation indicators. It
seems that perception of consequences can act as a buffer, helping MS patients prepare to con-
front relapse, just like recognizing the chronicity of the condition. What was described in the
research by Kunschitz [71] as an optimistic attitude based on resilience may in fact be an atti-
tude that denies the reality of functioning with a chronic illness, looking at the negative effects
of having FIP. The meta-analysis by Rivera et al. [36] suggested that lower levels of perception
Fig 4. Cross-lagged panel model of MSIS-29 and HADS over four timepoints for FIP (n = 27). Note: Solid arrows are p< .05; dashed arrows are nonsignificant;
numbers above arrows indicate standardized coefficients.
https://doi.org/10.1371/journal.pone.0258740.g004
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of consequences may be more adaptive, but the results suggest that it may also lead to adaptive
difficulties. Moderate levels of this factor appear to have relatively positive effects on quality of
life and emotional functioning.
On the basis of the results of repeated measures, making it possible to look into the adapta-
tion process, it seems possible to conclude that the cognitive profile is related to most adapta-
tion indicators, especially in the second part of the study (T2). Depression, anxiety, and quality
of life differed significantly, especially between RIP and FIP. Thus, the suggestion appears that
confronting reality and the absence of avoidant coping may lead the patient to seek useful solu-
tions in their daily struggles associated with MS. Non-significant differences between the clus-
ters when measuring depression (T1), anxiety (T1, T2, T3), and quality of life (T1 and T2) in
the early stages of the research may be due to the active process of acquiring disease experi-
ence. This is particularly the case when the first years of living with MS patients make it possi-
ble to gain experience of what the disease looks like, what its course will be like and what
possibilities there are of adapting to the difficulties that arise. As found in the literature,
patients are less likely to engage in health behaviors or comply with medical advice when their
illness perception is negative [39, 72, 73]
The age of the patients also differed between the clusters, with FIP represented by the oldest
group of patients. This is consistent with the literature on somatic conditions) [74] and mental
conditions [75], with older patients declaring negative illness perception (in cognitive and
emotional terms) and lower quality of life compared to younger patients.
Adaptation process
The study observed different trajectories of the adaptation process for the individual disease
perception types. Consequently, the assumptions concerning the third hypothesis were
confirmed.
In Anxious Illness Perception (AIP), the level of depressiveness and anxiety was a predictor
for subsequent measures in the initial phase of the study. However, it was not involved in
explaining their level in the final phase of the study conducted after several years. This is evi-
dence of the possible involvement of other explanatory variables in this process, at the same
time showing the absence of a direct relationship between how the patients functioned emo-
tionally in the early period of diagnosis and the later several-year period. Interestingly, depres-
siveness in the final measure is associated with lower levels of physical and psychological
quality of life. This indicates the need to take into account other variables that could signifi-
cantly explain the patients’ emotional state. Their illness representation is dominated by per-
ceptions of the consequences of the illness and the sense of chronicity, but at the same time
there is a moderate level of control favoring action while living with the illness.
An interesting association is also represented by depressiveness in the second measure as a
predictor of lower psychological quality of life in the third measure (or the perceived burden of
illness). This may suggest the potential value of monitoring the state of depression as contrib-
uting to negative psychological functioning in patients, but resulting, as the disease progresses,
from causes other than the state of depression itself.
In terms of quality of life (QoL), similar predictive relationships were observed for the phys-
ical and psychological dimensions, in this case also with regard to the final measure. Interest-
ingly, the psychological quality of life score on the third measure was a predictor of both
physical and psychological QoL, but the quality of life in the physical dimension made it possi-
ble to predict only the values of that dimension. This suggests a partial independence of the
subjective assessment of physical and mental state. At the same time, quality of life in the case
of this configuration of disease features appears to be a better measure of adaptation to
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multiple sclerosis. This may also be related to the measure used to assess quality of life that was
directly related to multiple sclerosis.
Research has confirmed that predictors of depression in multiple sclerosis include general
medical status or progressive disability [76, 77]. Predictors of anxiety in the disease discussed
here pose a greater challenge for researchers, as the findings are inconsistent and often do not
yield significant conclusions [76], while noting that anxiety levels are significantly higher in
MS patients than in the general population [78].
The observations obtained may also mean that the subjective assessment of the physical
effects of the disease explains at the beginning of the illness how the patient further evaluates
their physical, but also their mental condition. However, after four years, physical quality of
life is no longer that significant; only the assessment of the psychosocial consequences of the
disease determines the overall quality of life. Worrying about the future starts, along with a
subjective assessment of the limitations caused by the illness. Anxious illness perception may
be characterized by cognitive errors such as tunnel thinking, which may involve focusing on
selective aspects of the illness consistent with subjective perception of the latter [79]. This may
also imply the potential role of metacognitive beliefs about emotional state, which may signifi-
cantly alter the way of perceiving and experiencing the illness, as suggested in a group of
patients with diabetes [80].
Analyzing covariance between the variables in each measure, it was noted that in the initial
stage of the study (T2), higher levels of depressiveness were associated with lower levels of
physical quality of life, while higher levels of anxiety were associated with lower levels of psy-
chological quality of life. This may suggest that perceiving negative symptoms of the illness
may promote the emergence of a negativistic evaluation of the reality, while a state of anxiety
and elevated tension may be associated with imagining the future and the tendency to worry.
According to the concept by Moss-Morris [30], the anxiety associated with chronic illness
decreases over time, patients become accustomed to their illness and learn to live with it. This
is confirmed both by earlier analyses and by the non-significance of predictions at the begin-
ning and at the end of the study. Other research suggests that depression is more important in
explaining psychosocial functioning, as it was found to be associated with greater physical dis-
ability and lower levels of occupational functioning, while anxiety was not [81].
In Realistic Illness Perception (RIP), anxiety, depressiveness and physical quality of life in
each consecutive measure constituted predictors for the subsequent levels. An exception here
was psychological quality of life, which was not explained by any of the analyzed variables in
the final measure (T4). This suggests, on the one hand, the involvement of other factors
responsible for assessing patients’ psychological functioning, but, on the other hand, it high-
lights the value of monitoring emotional state and of subjective assessment of physical state by
the patients. An interesting observation is related to depressiveness at T2, as a positive predic-
tor for anxiety at the subsequent T3 measure. Anxiety, in turn, made it possible to predict
depressiveness at T4. In other words, the persistence of anxiety states potentially resulting
from the monitoring of the source of threat represented by the illness may, in a longer-term
perspective, mask depressive states. Such dynamics may also result from an increasing aware-
ness of physical limitations. This is consistent with research in which depressive states and feel-
ings of fatigue tended to persist, while the level of anxiety initially co-occurred but nevertheless
decreased over time and as the disease progressed [82]. Compared to the model for AIP,
patients with a realistic illness perception reduced their anxiety levels either more rapidly or
more effectively in the process of adaptation to illness. The role of depression in this process
can also be reflected upon–it represents a disproportionate emotional response to the patient’s
actual physical state. Through this emotional coping, all the patient’s resources are consumed,
and instead of coping with the disease in the surrounding reality, the patient focuses on their
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own emotional state with a self-referential attitude. Research confirms that higher levels of
depressiveness are observed during the first years of the disease [53, 54] and may be relatively
independent of the patient’s physical condition. In addition, Butler et al. [83] emphasize that
anxiety is often overshadowed by depressiveness.
On the other hand, lower levels of depressiveness in the final measure were associated with
lower values of both psychological and physical quality of life, suggesting that we may be deal-
ing with an apparent realism that favors negative emotions after several years of living with the
illness. Initially, anxiety and depression alternate, occurring from time to time at different
points during the course of the disease. Ultimately, this remission of depressive states is associ-
ated with a reduction in quality of life, probably through a mechanism of focusing on the real-
ity of living with the illness. Realistic illness perception is characterized by perceiving multiple
sclerosis as a chronic and cyclical condition that can remain under control, just like its treat-
ment. Moreover, this representation is not accompanied by a similar level of negative emotions
as in the case of an anxious or fatalistic illness perception. This is also consistent with the
research by Hanna and Strober [84], in which an interdependence was found between anxiety
and depression was observed, particularly among those with shorter illness duration.
Illness coherence is characteristic of this RIP representation. According to the salutogenic
model [85], coherence is an important resource for improving resilience to stress and threaten-
ing states. It can facilitate adaptation to illness and well-being [86]. The findings of Bassi et al.
[59] supported this interpretation: understanding a disease such as MS and accepting its basic
features (unknown etiology, highly variable symptoms, and unpredictable course) makes up a
global attitude that is positively related to satisfactory quality of life. However, it seems that the
process of giving coherence to the experience is lengthy, as the current study suggests. The
belief about treatment control present in this illness perception type suggests that even if MS
cannot be cured, confidence as to the effectiveness of treatment in controlling disease progres-
sion or the symptoms can be a valuable source of control, with positive consequences for the
patients’ well-being. A realistic approach to the core symptoms and progression of the disease
allows patients to get closer to the essence of the latter and to learn to live with disability, but at
the same time avoid looking towards the future. Similar conclusions come from longitudinal
studies on patients with esophageal cancer [46]
Among patients with fatalistic illness perception (FIP), depressiveness was a predictor of a
subsequent negative emotional state. Quality of life in the physical and psychological dimen-
sions also made it possible to predict subsequent values in further measures. High values of
depressive states favored the persistence of such states after several years of living with the ill-
ness, just as low quality of life was a predictor for similar values in the course of the illness.
Interestingly, as in the case of AIP, anxiety in the T4 measure was not explained by any vari-
able, while at the same time having the highest value in this disease representation.
In addition to similar observations in which the individual variables of anxiety, depressive-
ness, and quality of life were predictors of the value of subsequent measurements of the same
variables–significant relationships of depressiveness with anxiety and physical quality of life
were observed initially (T2), but this relationship ceased to be significant after four years. Per-
haps decreasing anxiety fostered confrontation with the negative vision of the disease. An
interesting relationship in the model is represented by the predictive values of psychological
quality of life, to some extent determining physical quality of life. A subjective perception of
the negative psychological consequences favored a negative perception of multiple sclerosis
symptoms (despite the absence of clear disease progression). It may seem that FIP involves
high costs in terms of emotion regulation, which can be reflected in the level of well-being.
Bassi et al. [59] demonstrated a relationship in which negative emotional representations were
associated with lower psychological well-being, life satisfaction, and emotional balance. This
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result is consistent with previous research showing that depression had a significant negative
effect on HRQoL among patients with multiple sclerosis [12]. The more MS patients tried to
distract themselves from the disease, the less they were able to gain insight into specific features
of the latter. Fundamental knowledge about the disease will help one to adapt well, but also to
return to everyday life–with possibilities and limitations.
One of the possible explanations for the interdependence between depressiveness and anxi-
ety and quality of life dimensions is based on resilience: over time, MS patients may know bet-
ter what they are dealing with, develop better regulation abilities, and have access to
psychological resources that sustain their psychological well-being. Research by Kasser and Zia
[87] suggested that resilience might be a protective factor against a decline in patients’ quality
of life and well-being despite disease progression. Resilience as such has been repeatedly stud-
ied in the aforementioned group [88–90]. It seems that supplementing the future model by
adding this construct may contribute more to the understanding of the dynamics of change in
the functioning of patients with multiple sclerosis.
In conclusion, it was found significant to perform the final measure at an unequal time
interval–among AIP patients, illness-related quality of life was a significant factor characteriz-
ing the adaptation process. Among those with RIP, depressiveness, anxiety and quality of life
were adaptation predictors, while among those with FIP, only depressiveness made it possible
to assess the level of adaptation. Such findings did not appear in previous measures, suggesting
the significance of long-term follow-up of patients and of identifying risk factors for the diffi-
culties in adapting to chronic illness. In other words, on the basis of the initial measurements
of individual characteristics, it was possible to predict patients’ functioning after several years.
The covariance of anxiety and depressiveness was significant for AIP patients, that of depres-
siveness and anxiety was significant for RIP patients, and that of depressiveness was significant
for FIP patients. In addition, each of the variables was a predictor of subsequent measures at
particular time intervals, illustrating the dynamics of change.
Limitations
Inference from the data obtained is subject to limitations for several reasons. Firstly, the
method itself and the specific points of measurement–the gap between the third and fourth
measurement may have been too large and numerous potential variables may exist affecting
adaptation outcomes, such as positive experiences, change in marital status, or change in treat-
ment. It would be useful to include social, personal and emotional resources–in addition to
cognitive factors such as illness perception–in the group of variables that may influence the
adaptation process. Secondly, the lack of an analysis of confounding variables in the time inter-
vals makes it impossible to conclude on the direct causal determinants of the level of adapta-
tion. The limited sample size also means that conclusions should be drawn with caution.
Thirdly, individuals with the relapsing-remitting type of MS were selected for the patient
group, with the exclusion of other types of multiple sclerosis. Moreover, the values of the vari-
ables may have been underestimated as the group included patients having access to the hospi-
tal environment. They were willing to take part in the study, possibly constituting a non-
representative group. Fourthly, specific variables related to the status of the disease were not
controlled for–health crises may have appeared at individual levels, contributing to the reactive
emergence of changes with regard to depressiveness, anxiety, or quality of life.
Conclusions
Despite the above limitations, a strength of the present study is the fact that it considered the
possible trajectories of change in the degree of adaptation to illness of patients with different
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illness perception types with regard to MS. Patients with RIP displayed lower anxiety and
depression levels and higher quality of life compared to AIP and FIP patients. Maintaining a
realistic illness perception along with low levels of anxiety and depression made it possible to
predict a good level of psychological functioning and higher quality of life compared to the
other groups. On the other hand, in the long-term perspective, depressiveness appeared to be
significant as an effect of confrontation with barriers caused by the illness. A group at risk of
difficulties in the process of adaptation to multiple sclerosis are individuals with a fatalistic or
negative perception of the disease. The dynamics of adaptation in this group of patients sug-
gested that they presented depressiveness as a response to living with the illness.
The practical application of the results obtained points to the significance of follow-up in
patients with positive/negative illness perception in terms of the unobvious consequences of
having such configurations. At the same time, it becomes important to work on reducing anxi-
ety in the early period of the disease, despite the focus on depressiveness in multiple sclerosis
that has prevailed so far. Illness perception can be a risk factor for patients’ lack of adaptation
to multiple sclerosis, which is why it becomes so important to analyze illness perception after
diagnosis, particularly when there is a risk of lack of further contact with the patients. Deter-
mining the illness perception type shortly after diagnosis can also help to identify individuals
belonging to the group of increased risk of failure to adapt, thus making early psychological
intervention possible.
To recapitulate, reference made to the patients’ illness perception by the specialist may fos-
ter willingness to engage in medical contact and comply with the recommendations. Previous
research has shown that realistic illness perception is recognized correctly as a treatment goal
[61, 91], and interventions related to illness perception have shown promising results in
patients with chronic diseases [61].
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76. Silva AM, Vilhena E, Lopes A, Santos E, Gonçalves MA, Pinto C, et al. Depression and anxiety in a Por-
tuguese MS population: associations with physical disability and severity of disease. Journal of the neu-
rological sciences. 2011; 306(1–2):66–70. https://doi.org/10.1016/j.jns.2011.03.042 PMID: 21497358
77. Gay MC, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta
Neurol Scand 2010; 121(3):161–70 https://doi.org/10.1111/j.1600-0404.2009.01232.x PMID:
20070277
78. Dahl O, Stordal E, Lydersen S, Midgard R. Anxiety and depression inmultiple sclerosis. Acomparative
population-based study inNord-Trondelag County, Norway. Mult Scler 2009; 15:1495–501 https://doi.
org/10.1177/1352458509351542 PMID: 19965515
79. Bear HA, Krause KR, Edbrooke-Childs J, Wolpert M. Understanding the illness representations of
young people with anxiety and depression: A qualitative study. Psychol Psychother [Internet]. 2021;
(papt.12345). Available from: https://doi.org/10.1111/papt.12345 PMID: 33960606
80. Purewal R, Fisher PL. The contribution of illness perceptions and metacognitive beliefs to anxiety and
depression in adults with diabetes. Diabetes Res Clin Pract. 2018; 136:16–22. https://doi.org/10.1016/j.
diabres.2017.11.029 PMID: 29203257
81. Gill S, Santo J, Blair M, Morrow SA. Depressive symptoms are associated with more negative functional
outcomes than anxiety symptoms in persons with multiple sclerosis. J Neuropsychiatry Clin Neurosci.
2019 Winter; 31(1):37–42. https://doi.org/10.1176/appi.neuropsych.18010011 PMID: 30187820
82. Wood B, van der Mei IAF, Ponsonby A-L, Pittas F, Quinn S, Dwyer T, et al. Prevalence and concurrence
of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler. 2013; 19(2):217–24.
https://doi.org/10.1177/1352458512450351 PMID: 22729988
83. Butler E., Matcham F., Chalder T. A systematic review of anxiety amongst people with Multiple Sclero-
sis Mult. Scler. Relat. Disord., 10 (2016) 145–68
84. Hanna M, Strober LB. Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences,
and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020; 44
(102261):102261.
PLOS ONE Identification of illness perception schema in multiple sclerosis - a 5-year prospective study
PLOS ONE | https://doi.org/10.1371/journal.pone.0258740 October 28, 2021 25 / 26
85. Antonovsky A. Unraveling the mystery of health: How people manage stress and stay well. New York,
NY: Jossey-Bass; 1987.
86. Eriksson M, Lindström B. Antonovsky’s sense of coherence scale and the relation with health: a system-
atic review. J Epidemiol Community Health. 2006; 60(5):376–381. https://doi.org/10.1136/jech.2005.
041616 PMID: 16614325
87. Kasser SL, Zia A. Mediating role of resilience on quality of life in individuals with multiple sclerosis: A
structural equation modeling approach. Arch Phys Med Rehabil. 2020; 101(7):1152–61 https://doi.org/
10.1016/j.apmr.2020.02.010 PMID: 32169458
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